PERSERIS

海倫司國際控股有限公司🇨🇦 Health Canada

Approval Id: bb49c7369b8a846a
Drug Approval Canada Name: PERSERIS
Product Name: PERSERIS
Status: Cancelled Post Market
Status Date: 2024-07-26
Original Market Date: 2021-06-15
Din: 02507846
Drug Class: Human
Dosage Form: Kit , Powder For Suspension, Sustained-Release
Route Of Administration: Subcutaneous
Schedule: Prescription
Ahfs: 28:16.08.04
Atc Original: N05AX08 RISPERIDONE
Atc Name: n 05 ax 08
Aig Number: 0124332014
Company Name: 海倫司國際控股有限公司
Company Address: 10 Carlson Court, Suite 701, Etobicoke, Ontario, Canada, M9W 6L2

RISPERIDONE

120 MG / SYR

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

bb49c7369b8a846a

Type

Standard